Vital Farms (NASDAQ:VITL - Free Report) had its price objective decreased by Jefferies Financial Group from $45.00 to $41.00 in a report issued on Monday morning,Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock.
Other research analysts have also recently issued research reports about the stock. DA Davidson raised their target price on shares of Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a report on Thursday, October 10th. TD Cowen decreased their target price on shares of Vital Farms from $46.00 to $41.00 and set a "buy" rating on the stock in a research note on Friday. Finally, Stifel Nicolaus decreased their target price on shares of Vital Farms from $42.00 to $34.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Vital Farms currently has a consensus rating of "Moderate Buy" and a consensus target price of $39.20.
Get Our Latest Stock Analysis on Vital Farms
Vital Farms Price Performance
NASDAQ VITL traded down $1.63 during trading hours on Monday, reaching $29.28. 2,387,779 shares of the stock traded hands, compared to its average volume of 783,857. The stock has a 50 day simple moving average of $35.01 and a two-hundred day simple moving average of $36.72. Vital Farms has a 1 year low of $11.72 and a 1 year high of $48.41. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.50 and a quick ratio of 3.03. The company has a market cap of $1.26 billion, a price-to-earnings ratio of 27.69 and a beta of 0.97.
Vital Farms (NASDAQ:VITL - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.14 by $0.02. Vital Farms had a return on equity of 23.29% and a net margin of 8.68%. The firm had revenue of $145.00 million for the quarter, compared to the consensus estimate of $145.27 million. During the same quarter in the previous year, the business earned $0.10 earnings per share. The company's quarterly revenue was up 31.3% on a year-over-year basis. On average, analysts predict that Vital Farms will post 1.1 EPS for the current fiscal year.
Insider Buying and Selling at Vital Farms
In other Vital Farms news, CEO Russell Diez-Canseco sold 44,653 shares of the business's stock in a transaction on Monday, October 14th. The shares were sold at an average price of $40.07, for a total transaction of $1,789,245.71. Following the transaction, the chief executive officer now directly owns 537,349 shares of the company's stock, valued at approximately $21,531,574.43. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Vital Farms news, CEO Russell Diez-Canseco sold 44,653 shares of the business's stock in a transaction on Monday, October 14th. The shares were sold at an average price of $40.07, for a total transaction of $1,789,245.71. Following the transaction, the chief executive officer now directly owns 537,349 shares of the company's stock, valued at approximately $21,531,574.43. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Matthew Ohayer sold 24,000 shares of the business's stock in a transaction on Monday, October 21st. The shares were sold at an average price of $39.09, for a total transaction of $938,160.00. Following the transaction, the insider now directly owns 7,194,777 shares in the company, valued at approximately $281,243,832.93. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 27.60% of the company's stock.
Institutional Trading of Vital Farms
A number of hedge funds have recently modified their holdings of the business. Van ECK Associates Corp boosted its stake in Vital Farms by 8.6% in the 2nd quarter. Van ECK Associates Corp now owns 4,095 shares of the company's stock worth $192,000 after purchasing an additional 323 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its stake in Vital Farms by 4.4% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 7,857 shares of the company's stock worth $276,000 after purchasing an additional 329 shares in the last quarter. Lifestyle Asset Management Inc. boosted its stake in Vital Farms by 6.5% in the 3rd quarter. Lifestyle Asset Management Inc. now owns 9,846 shares of the company's stock worth $345,000 after purchasing an additional 598 shares in the last quarter. CWM LLC boosted its stake in Vital Farms by 162.9% in the 2nd quarter. CWM LLC now owns 1,057 shares of the company's stock worth $49,000 after purchasing an additional 655 shares in the last quarter. Finally, nVerses Capital LLC boosted its stake in Vital Farms by 66.7% in the 2nd quarter. nVerses Capital LLC now owns 2,000 shares of the company's stock worth $94,000 after purchasing an additional 800 shares in the last quarter. Institutional investors own 98.59% of the company's stock.
About Vital Farms
(
Get Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
See Also
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.